Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Tofacitinib 11mg Tablet
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹499/-
Tofatake ER 11 Tablet contains Tofacitinib 11mg in an extended-release formulation. Tofacitinib is a Janus kinase (JAK) inhibitor that modulates immune response by inhibiting JAK1 and JAK3 enzymes, which play a key role in the pathogenesis of inflammatory and autoimmune diseases. The extended-release version provides sustained drug levels over 24 hours, allowing for once-daily dosing, improving patient compliance and maintaining therapeutic efficacy throughout the day.
Tofatake ER 11 is indicated in the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, especially in patients who have had an inadequate response or intolerance to conventional disease-modifying antirheumatic drugs (DMARDs).
Common side effects may include headache, diarrhea, nasopharyngitis, and hypertension. Serious risks include increased risk of infections, blood clots, elevated liver enzymes, and changes in blood lipid levels. Regular monitoring is recommended.
Tofatake ER 11 Tablet is indicated for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis who have not responded adequately to previous DMARDs or biologic therapies. It helps reduce joint pain, stiffness, inflammation, and improves physical function in autoimmune conditions by controlling abnormal immune responses.
Use only under supervision of a specialist. Not recommended for use in patients with active serious infections, liver impairment, or those on strong immunosuppressants. Routine CBC, LFT, and lipid profile monitoring is advised during therapy.
Store in a cool, dry place away from direct sunlight.
Composition : Cefpodoxime Proxetil (100mg/5ml)
Composition : Cefixime (100mg/5ml)
Composition : Cefalexin (125mg)
Composition : Clarithromycin (125mg)
Composition : Cefixime (50mg/5ml)
Composition : Cefuroxime (125mg)
Composition : Cefpodoxime Proxetil (50mg) + Clavulanic Acid (31.25mg)
Composition : Cefpodoxime Proxetil (100mg) + Clavulanic Acid (62.5mg)
Composition : Cefixime (50mg/5ml) + Clavulanic Acid (31.25mg/5ml)
Composition : Cefuroxime (125mg) + Clavulanic Acid (31.25mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation